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Abstract
Objective:  To  review  the  literature  about  the  prevalence  of  vitamin  D  deﬁciency  and  its  con-
sequences in  children  and  adolescents  with  sickle-cell  disease.
Data sources:  The  literature  survey  was  performed  through  the  bibliographic  databases  MED-
LINE; U.S.  National  Library  of  Medicine  and  National  Institutes  of  Health  (PubMed);  Literatura
Latino-Americana  e  do  Caribe  em  Ciências  da  Saúde  (Lilacs),  and  the  Cochrane  Library.  The
keywords were  selected  using  Medical  Heading  Terms  (MeSH):  ‘‘vitamin  D’’  OR  ‘‘vitamin  D  deﬁ-
ciency’’ AND  ‘‘anemia,  sickle  cell’’  AND  ‘‘child’’  AND  ‘‘adolescent’’.  The  search  was  limited
to articles  in  English,  Spanish  and  Portuguese,  published  until  April  2014.
Data synthesis:  Eleven  articles  were  selected  among  the  18  found.  In  6  of  the  11  studies,
serum levels  of  vitamin  D  in  children  and/or  adolescents  with  sickle-cell  anemia  were  low.
The prevalence  of  vitamin  D  deﬁciency  in  patients  with  sickle-cell  anemia  exceeded  that  of
the comparison  group.  The  low  intake  of  vitamin  D,  seasonality,  exposure  to  sun,  increased
metabolism  associated  with  the  hemoglobinopathy,  and  age  increase  were  factors  associated
with the  deﬁciency.  There  was  an  association  between  a  signiﬁcant  vitamin  D  deﬁciency
and bone  weakness  and  painful  crises.  There  was  a  positive  correlation  between  increased
levels of  vitamin  D  by  supplementation  and  functional,  physical  capacity.
Conclusions:  The  vitamin  D  deﬁciency  in  children  and  adolescents  with  sickle-cell  disease  is
prevalent and  requires  further  studies  to  demonstrate  its  association  with  comorbidities  and
possible beneﬁts  of  vitamin  D  supplementation.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.09.008
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Vitamina  D  em  crianc¸as e  adolescentes  com  doenc¸a falciforme:  uma  revisão
integrativa
Resumo
Objetivo:  Revisar  a  literatura  sobre  a  frequência  da  deﬁciência  de  vitamina  D  e  suas  conse-
quências em  crianc¸as  e  adolescentes  com  anemia  falciforme.
Fontes  de  dados:  O  levantamento  bibliográﬁco  foi  feito  nas  bases  bibliográﬁcas  MEDLINE,  U.S.
National Library  of  Medicine  e  National  Institutes  of  Health  (PubMed),  Literatura  Latino-
Americana  e  do  Caribe  em  Ciências  da  Saúde  (Lilacs)  e  Cochrane.  Os  descritores  foram
selecionados  com  o  uso  do  Medical  Heading  Terms  (MeSH):  ‘‘vitamin  D’’  OU  ‘‘vitamin  D  deﬁ-
ciency’’ E  ‘‘anemia,  sickle  cell’’  E  ‘‘child’’  E  ‘‘adolescent’’.  A  busca  limitou-se  aos  artigos  em
inglês, espanhol  e  português,  com  data  de  publicac¸ão  até  abril  de  2014.
Síntese  dos  dados: Foram  selecionados  11  estudos,  entre  os  18  encontrados.  A  pesquisa  revelou
que os  níveis  séricos  de  vitamina  D  em  crianc¸as  e/ou  adolescentes  com  anemia  falciforme
encontram-se  baixos  em  seis  de  11  artigos  analisados.  Essa  frequência  de  deﬁciência  de  vitamina
D em  pacientes  com  anemia  falciforme  excede  a  do  grupo  de  comparac¸ão  saudável.  A  baixa
ingesta de  vitamina  D,  a  sazonalidade,  a  exposic¸ão  solar,  o  metabolismo  aumentado  próprio  da
hemoglobinopatia  e  o  aumento  da  idade  são  fatores  associados  à  deﬁciência.  Houve  associac¸ão
entre deﬁciência  signiﬁcativa  de  vitamina  D  e  fraqueza  óssea  e  crises  dolorosas.  Há  correlac¸ão
positiva entre  aumento  dos  níveis  de  vitamina  D  por  meio  da  suplementac¸ão  e  a  capacidade
funcional física.
Conclusões:  A  deﬁciência  de  vitamina  D  em  crianc¸as  e  adolescentes  com  doenc¸a  falciforme
é prevalente  e  necessita  de  mais  estudos  para  evidenciar  a  sua  relac¸ão  com  comorbidades  e
possíveis benefícios  da  suplementac¸ão  da  vitamina  D.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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Medicine  and  the  National  Institutes  of  Health  (PubMed)ntroduction
ickle  cell  disease  is  caused  by  a  mutation  resulting  from
n  exchange  of  nitrogenous  bases  in  the  sixth  codon  of
he  beta-globulin  hemoglobin  gene,  generating  an  abnormal
emoglobin  called  hemoglobin  S  (HbS).1 The  manifestations
f  sickle-cell  disease  are  due  to  the  presence  of  HbS,  of
hich  molecules  are  organized  into  polymeric  beams  when
eoxygenated  and  give  the  RBC  an  elongated  and  rigid
onformation,  called  a  ‘‘sickle-shaped  red  blood  cell’’.2
fter  the  sickling  process,  the  red  blood  cells  begin  to
how  changes  in  membrane  proteins  and  increased  expres-
ion  of  adhesion  molecules  that,  consequently,  lead  to
ed  blood  cell  adhesion  to  the  endothelium.  This  process
riggers  an  inﬂammatory  phenomenon,  activation  of  coagu-
ation,  hypoxia,  ischemia  and  local  infarction,  in  addition  to
educed  RBC  survival.2 Sickle-cell  disease  is  one  of  the  most
ommon  genetic  diseases  in  Brazil  and  in  the  world.3 The
hronic  hemolysis,  anemia,  and  vaso-occlusive  phenomena
hat  occur  in  patients  with  the  disease  are  triggers  of
n  accelerated  metabolism,  and  this  process  leads  to  a
asal  metabolic  rate  20%  higher  in  patient  with  sickle-cell
nemia  than  in  the  normal  population.1,4 However,  there
re  no  records  of  methodologies  and  equations  to  esti-
ate  the  energy  expenditure  in  children  with  sickle-cell
nemia.5
Children  with  sickle  cell  anemia  have  a  higher  risk
f  developing  nutritional  deﬁciencies  due  to  reduced
ppetite,6 poor  dietary  intake  of  nutrients7 and  infec-
ious  complications,  which  demands  greater  attention  from
i
C
mealth  professionals.  Among  the  vitamins,  vitamin  D  must  be
arefully  evaluated  in  children  with  sickle-cell  anemia.  This
s  due  to  the  high  concentration  of  melanin  in  the  skin,  low
evels  of  physical  activity,8 and  low  food  intake.7,9 Children
ith  sickle-cell  anemia  are  more  likely  to  develop  vitamin
 deﬁciency  when  compared  to  the  healthy  controls.10 Cal-
ium  and  vitamin  D  are  important  for  bone  metabolism,  and
he  low  calcium  intake  leads  to  a  reduction  in  the  ideal
one  mass  peak  in  children  and  adolescents  with  sickle-
ell  anemia,  which  determines  growth  failure.11 Vitamin  D
eﬁciency,  in  turn,  is  associated  with  increased  respiratory
nfections,  muscle  weakness  and  increased  risk  of  falls  and
icrolesions.12 Additionally,  in  children  with  sickle-cell  ane-
ia,  whose  bones  are  affected  by  infarction,  osteoporosis
nd  osteonecrosis,  vitamin  D  deﬁciency  may  worsen  bone
ondition.13
Considering  these  facts,  this  study  aimed  to  carry  out
n  integrative  literature  review  to  analyze  the  frequency  of
itamin  D  deﬁciency  and  its  consequences  in  children  and
dolescents  with  sickle-cell  anemia.
iterature review
or  the  literature  review,  data  searches  were  carried  out
n  the  MEDLINE  databases;  at  the  US  National  Library  ofnterface;  Literatura  Latino-Americana  e  do  Caribe  em
iências  da  Saúde  (LILACS),  and  the  Cochrane  Library.  To
ake  up  the  search  strategy,  the  descriptors  were  selected
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SVitamin  D  in  children  and  adolescents  with  sickle  cell  diseas
using  Medical  Subject  Heading  Terms  (MeSH).  Those  terms
were  used  for  the  search  in  the  MEDLINE  database,  and
subsequently  adapted  and  translated  into  Spanish  and  Por-
tuguese  for  the  search  in  other  databases.  The  following
parameters  were  used:  ‘‘vitamin  D’’  OR  ‘‘vitamin  D  deﬁ-
ciency’’  AND  ‘‘anemia,  sickle  cell’’  AND  ‘‘child’’  AND
‘‘adolescent’’.
Inclusion  criteria  for  the  selection  were  articles  published
in  English,  Portuguese  and  Spanish,  with  a  study  population
in  the  age  range  of  children  and  adolescents,  younger  than
18  years  old,  with  sickle-cell  disease.  Exclusion  criteria  were
animal  studies  and  human  studies  that  did  not  include  the
predetermined  age  range  and  that  had  no  association  with
sickle-cell  anemia.  No  time  limit  was  considered  for  the  bib-
liographic  search.  The  reference  search  was  carried  out  from
December  2013  to  April  2014.
To  eliminate  article  duplication,  documents  were
ordered  by  titles  and  authors,  and  those  that  appeared
more  than  once  were  excluded.  For  the  selection  of  stud-
ies,  a  review  of  titles  and  abstracts  was  performed.  After
the  ﬁrst  review,  18  articles  were  selected:  2  from  the
Cochrane  Library  database,  15  from  PubMed  and  1  from
LILACS  database.  After  the  initial  selection,  a  new  text
evaluation  was  carried  out  in  full  texts,  resulting  in  the
exclusion  of  7 items.  These  articles  were  excluded,  as  they
did  not  contemplate  the  age  range  described  in  the  inclu-
sion  criteria.  At  the  end  of  the  evaluation,  we  selected  one
article  from  the  Cochrane  database  and  10  from  the  Pubmed
database.
The  studies  were  entered  in  a  Microsoft  Ofﬁce  Excel
2007® spreadsheet  with  recorded  information  on  title,
authors,  journal,  year  of  publication,  objective,  study
design,  population,  level  of  evidence,  main  results  and
conclusions  of  the  study.  The  developed  studies  had  their
experimental  protocols  approved  by  the  Institutional  Review
Board  of  the  respective  institutions.  Because  this  is  a  review
and  update  on  the  subject,  the  present  study  was  not  sub-
mitted  to  the  Institutional  Review  Board  at  our  institution.
The  aforementioned  hierarchization  based  on  the  level
of  evidence  was  carried  out  following  the  classiﬁcation
methodology  according  to  study  design,  which  categorizes
the  studies  in  seven  levels.14,15 In  the  ﬁrst  level,  the  evi-
dence  is  derived  from  systematic  review  or  meta-analysis  of
all  relevant  randomized  controlled  clinical  trials;  at  level  2,
from  at  least  one  randomized,  controlled  and  well-designed
clinical  trial;  in  level  3,  evidence  from  well-designed  clinical
trials,  without  randomization;  level  4,  evidence  from  well-
designed  cohort  and  case-control  studies;  level  5,  results
of  systematic  review  of  descriptive  and  qualitative  stud-
ies;  level  6,  evidence  derived  from  descriptive  or  qualitative
study,  and  level  7,  evidence  from  experts’  opinions  and/or
reports  of  expert  committees.
The  ﬁnal  review  sample  consisted  of  11  articles,  of  which
representations  are  shown  in  Table  1.
DiscussionSerum  levels  of  vitamin  D  and  sickle  cell  anemia
In  the  selected  studies,  vitamin  D  deﬁciency  was  treated  as
an  object  of  primary  or  secondary  research,  when  associ-
D
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ted  to  the  main  subject  of  the  study.  According  to  Dietary
eference  Intakes,  vitamin  D  deﬁciency  occurs  when  serum
5-hydroxyvitamin  D  levels  are  <11ng/mL.11
Seven  of  the  nine  articles  analyzed  serum  vitamin  D  levels
n  children  and/or  adolescents  with  sickle-cell  disease  and
howed  a deﬁciency  of  this  nutrient.9,16--21 Jackson  et  al.,  in  a
ohort  of  children  in  whom  vitamin  D  levels  were  measured,
ound  that  96.4%  had  vitamin  D  deﬁciency  and,  of  these,
4.0%  had  severe  deﬁciency  (<10ng/mL);  1.4%  had  insufﬁ-
ient  levels,  and  only  three  children  (2.2%)  had  adequate
evels.16 Van  der  Dijs  et  al.  observed  that,  when  compared  to
ealthy  controls,  patients  with  sickle-cell  anemia  had  lower
erum  calcium  concentrations.  These  levels,  however,  were
ot  below  the  reference  values.  In  the  same  study,  there  was
o  difference  between  the  groups  regarding  the  phosphate,
arathormone  and  vitamin  D  levels.22 However,  other  stud-
es  demonstrated  that  the  frequency  of  low  serum  levels  of
itamin  D  in  the  group  with  sickle-cell  anemia  exceeded  the
requency  found  in  the  healthy  group.9,10
Due  to  the  participation  of  solar  radiation  in  vita-
in  D  metabolism,  a  review  study  evaluated  seasonal
ariations,  demonstrating  higher  serum  levels  of  vitamin
 in  the  seasons  with  higher  temperatures,  spring  and
ummer.9,16 In  another  study,  however,  this  variation  was  not
emonstrated.18
Another  determining  factor  for  the  adequacy  of  serum
evels  of  vitamin  D  and  calcium  is  proper  food  intake.  In
ickle-cell  disease,  nutritional  needs  are  greater  due  to  the
igher  energy  requirement.10 Studies  evaluating  food  intake
f  subjects  that  had  vitamin  D  deﬁciency  have  shown  that
ietary  intake  of  the  vitamin  is  not  appropriate.9,10 The
ntake  of  vitamin  D  was  below  the  recommended  values  of
00  IU  (5  mg/day).9,11 The  low  consumption  of  milk,  source
f  calcium  and  vitamin  D,  tends  to  decline  even  more  with
ge,  leading  to  increasingly  lower  serum  levels  of  vitamin
ith  increasing  age.9
The  difference  during  the  aging  process  was  also  demon-
trated  by  Garrido  et  al.,  who  reported  low  serum  levels
f  vitamin  D  in  children  younger  than  5  years,  but,  in  chil-
ren  older  than  5  years,  this  deﬁciency  was  even  higher.  No
hild  older  than  5  years  showed  acceptable  levels  of  vita-
in  D.18 These  results  are  in  parallel  with  another  study,
hich  showed  an  inverse  correlation  between  the  levels  of
itamin  D  and  age,  that  is,  the  older  the  age,  the  lower  the
evels  of  vitamin  D.  In  this  study,  osteocalcin  serum  levels
ere  lower  than  those  found  in  healthy  children,  which  may
e  a  consequence  of  vitamin  D  deﬁciency.20 Osteocalcin,
hich  participates  in  bone  mineralization,  is  synthesized  by
steoblasts,  and  their  induction  occurs  by  vitamin  D3.  Osteo-
alcin  levels  are  higher  during  childhood,  and  their  peak
ccurs  during  puberty.23 This  fact  could  explain  the  inverse
orrelation,  as  the  older  the  age,  the  higher  the  production
f  osteocalcin.
erum  levels  of  vitamin  D  and  comorbidities
ome  selected  studies  assessed  the  association  of  vitamin
 deﬁciency  with  comorbidities  in  patients  with  sickle-
ell  anemia.9,16,17,20,21,24 Jackson  et  al.,  in  a retrospective
tudy,  aimed  to  evaluate  the  association  of  vitamin  D  deﬁ-
iency  with  painful  crises  and  asthma  attacks  in  children
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Table  1  Summary  of  selected  articles  for  the  review:  sickle  cell  disease  and  vitamin  D.
Reference  Level  of  evidence  Sample  (n)  Conclusion
Osunkwo  et  al.27 2  46  The  results  suggest  the  potential  beneﬁt  of  vitamin  D
supplementation  in  the  reduction  of  the  number  of  days  with
pain in  sickle  cell  disease.
Shams et  al.28 2  58  Vitamin  D  administration  was  associated  with  lower
postoperative  analgesia  requirement  and  postoperative
complications.
Jackson et  al.16 6  139  Low  levels  of  vitamin  D  were  associated  with  lung  function,
but were  not  associated  with  painful  crises  and  acute  chest
syndrome.
Osunkwo et  al.17 6  53  Patients  with  sickle-cell  disease  have  a  tendency  to  vitamin  D
deﬁciency,  and  research  suggests  an  association  between
vitamin  D  deﬁciency  and  bone  fragility.
Garrido et  al.18 6  78  Vitamin  D  deﬁciency  was  prevalent  in  children  with  sickle-cell
disease in  Madrid.
Van der  Dijs  et  al.22 6  18  The  vitamin  D  levels  in  patients  with  sickle-cell  anemia  in
Curacao  are  appropriate.
Chapelon,  et  al.19 6  53  A  slight  decrease  in  bone  mineral  density,  unrelated  to  vitamin
D deﬁciency,  was  found  in  children  with  sickle-cell  disease,
beginning  at  puberty  and  being  more  marked  among  females.
Buison et  al.9 6  65  Low  serum  levels  of  vitamin  D  had  a  high  prevalence  in
children  with  sickle-cell  disease  and  were  associated  with
seasonal  variations  and  diet.
Rovner et  al.10 6  150  The  risk  of  individuals  with  sickle-cell  disease  to  have  vitamin
D deﬁciency  was  5.3  times  higher  than  that  of  healthy
subjects.
Lal et  al.20 6  25  Children  with  severe  manifestations  of  sickle-cell  disease  have
low bone  density,  as  well  as  a  diet  poor  in  calcium  and  vitamin
D. Vitamin  D  deﬁciency  was  higher  in  patients  whose  weight
and/or height  were  below  average.
Ozen et  al.21 6  50  The  results  suggest  the  potential  beneﬁt  of  vitamin  D
supplementation  on  reducing  the  number  of  days  with  pain  in
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sith  sickle-cell  anemia.  Although  vitamin  D  deﬁciency  was
revalent  in  the  population,  the  study  found  no  statistical
ssociation  between  vitamin  D  deﬁciency  and  the  number
f  painful  crises  and  asthma.16 Osunkwo  et  al.  assessed
3  children  and  adolescents  with  sickle-cell  anemia,  of
hich  32%  had  chronic  pain,  and  42%,  bone  fragility.  A  signiﬁ-
ant  association  was  observed  between  vitamin  D  deﬁciency
nd  painful  crises.  The  same  study  also  found  an  association
etween  low  vitamin  D  levels  and  bone  weakness.17
In  sickle  cell  anemia,  the  bone  can  be  affected  by
icroinfarctions,  osteopenia,  osteonecrosis,  osteoporosis
nd  osteomyelitis.25 Risk  factors  for  the  occurrence  of
steopenia  in  sickle-cell  disease  include  delayed  puberty
nd  the  low  competence  of  bone  mass  metabolism
eak,  microinfarctions  resulting  from  vaso-occlusive  events,
hronic  pain  with  immobilization,  and  of  the  efﬁciency  of
alcium,  vitamin  D  and  other  nutrients.20,26
Low  levels  of  vitamin  D  are  associated  with  the  decrease
n  mineral  acquisition  by  the  bone.9,24 Lal  et  al.  observed  sig-
iﬁcant  bone  density  deﬁcit  in  the  proximal  end  of  the  femur
nd  lumbar  spine  in  children  with  severe  manifestations
f  sickle-cell  anemia.  There  was  no  correlation  between
he  intake  of  calcium  or  vitamin  D  and  bone  density.  In  the
ame  study,  however,  there  was  a  strong  negative  correlation
c
s
lckle-cell  disease
etween  vitamin  D  values  and  serum  levels  of  alkaline  phos-
hatase,  suggesting  that  vitamin  D  signiﬁcantly  affected
one  metabolism  in  these  patients.20 In  the  study  by  Ozen
t  al.,  an  insufﬁcient  intake  of  vitamin  D  was  observed,
hich  was  more  signiﬁcant  among  patients  with  osteopenia
nd  osteoporosis,  compared  to  those  without  alterations,
hich  demonstrates  the  importance  of  adequate  vitamin  D
ntake  for  the  prevention  of  comorbidities.21
itamin  D  supplementation
here  are  few  studies  that  addressed  vitamin  D  supplemen-
ation  in  children  and  adolescents  with  sickle-cell  anemia.
n  our  review,  we  found  only  three  studies.  The  study  by
arrido  et  al.,  which  assessed  the  status  of  vitamin  D  in  chil-
ren  with  sickle-cell  anemia  in  Spain,  observed  that  vitamin
 levels  in  children  younger  than  1  year  were  below  appro-
riate  levels,  despite  the  supplementation.  The  vitamin  D
upplementation,  in  this  situation,  promoted  a  vitamin  deﬁ-
iency  stabilization,  preventing  the  development  of  a  more
evere  deﬁciency.18
Osunkwo  et  al.,  in  a  pilot  randomized  clinical  trial,  ana-
yzed  supplementation  with  500  mg  of  calcium  and  200  IU
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RVitamin  D  in  children  and  adolescents  with  sickle  cell  diseas
of  vitamin  D  for  a  period  of  6  months  in  46  subjects
with  sickle-cell  anemia,  aged  7--21  years.  The  patients,
previously  diagnosed  with  vitamin  D  deﬁciency  by  serum  25-
hydroxyvitamin  D  measurements,  were  randomly  assigned  to
receive  calcium  and  vitamin  D  supplementation  or  placebo.
During  the  study,  the  recording  of  painful  crises  and  the
assessment  of  quality  of  life  scores  in  the  physical  domain
were  performed,  to  which  scores  were  attributed  regarding
the  patient’s  performance  of  everyday  activities.  The  results
showed  an  inverse  correlation  between  vitamin  D  levels
and  the  incidence  of  pain,  demonstrating  that  the  higher
the  levels  of  vitamin  D,  the  lower  the  incidence  of  painful
crises.  There  were  also  positive  correlations  between  vita-
min  D  levels  and  the  physical  domain  scores,  demonstrating
the  beneﬁts  of  vitamin  D  for  the  quality  of  life  of  these
patients.27
In  the  study  by  Shams  et  al.,  58  children  with  sickle-cell
anemia  were  randomly  divided  into  two  groups,  one  of  which
received  daily  supplementation  of  400  IU  of  vitamin  D  for  a
period  of  6  months  prior  to  circumcision  surgery,  while  the
other  group  received  no  intervention  before  the  procedure.
In  the  postoperative  period,  the  groups  were  evaluated  for
the  need  of  analgesia,  the  presence  of  pain  and  the  occur-
rence  of  complications  related  to  sickle-cell  disease,  such
as  cerebrovascular  accidents  and  painful  crises,  as  well  as
those  unrelated  to  sickle-cell  disease,  such  as  fever  and
infection  signs.  Vitamin  D  administration  was  associated
with  a  lower  incidence  of  postoperative  complications  asso-
ciated  with  sickle-cell  anemia,  as  well  as  less  need  for
analgesia  postoperatively.28
The  aforementioned  studies  bring  results  from  small  pop-
ulation  samples,  with  the  ﬁrst  one  being  a  pilot  study.
Additionally,  the  second  study  was  carried  out  with  male
patients  only,  submitted  to  minor  surgery,  which  results  in
limited  external  validity.  Due  to  the  low  number  of  clini-
cal  trials  included  in  this  review  that  analyzed  vitamin  D
supplementation  in  children  and  adolescents  with  sickle-cell
disease,  the  beneﬁts  of  this  supplementation  for  this  pop-
ulation  are  not  conclusive  yet,  demonstrating  the  need  for
further  studies  on  this  subject.
Final considerations
The  performance  of  this  review  and  the  small  number  of
identiﬁed  articles  shows  the  scarcity  of  studies  on  the  nutri-
tional  status  of  children  and  adolescents  with  sickle-cell
disease  and  the  inﬂuence  of  vitamin  D  on  the  clinical  pro-
ﬁle  of  these  patients.  There  were  no  studies  carried  out  in
Brazil.  It  should  be  noted  that  the  review  was  performed
using  the  keywords  in  Portuguese,  Spanish  and  English,
and  no  time  limit  was  established.  Although  many  stud-
ies  reported  on  the  prevalence  of  vitamin  D  deﬁciency
in  children  and  adolescents  with  sickle-cell  disease,  its
consequences  and  the  effects  of  supplementation  are  incon-
sistent.
According  to  the  literature,  vitamin  D  deﬁciency  is
common  in  this  population.  It  also  showed  a  signiﬁcant  dif-
ference  in  deﬁciency  when  the  study  group  was  compared
with  healthy  subjects.  As  for  causes,  the  inﬂuence  of  nutri-
ent  intake  and  higher  dietary  requirements,  seasonality  and
sun  exposure,  age  and  common  disease  complications,  such
1353
s  bone  infarctions,  was  demonstrated.  As  for  the  associa-
ion  between  serum  levels  of  vitamin  D  and  comorbidities,
he  results  are  still  controversial,  showing  a possible  associ-
tion  of  vitamin  D  deﬁciency  with  the  occurrence  of  painful
rises,  decreased  physical  performance  and  impaired  bone
etabolism.  In  studies  in  which  vitamin  D  and  calcium
upplementation  intervention  was  performed,  an  associ-
tion  between  adequate  levels  of  vitamin  D  and  the
mprovement  in  the  patient’s  quality  of  life  related  to  phys-
cal  performance  and  reduction  of  complications  associated
r  not  with  sickle-cell  disease  and  pain  in  the  postoperative
eriod  was  demonstrated.
It  can  be  concluded,  with  this  review,  that  vitamin  D  deﬁ-
iency  in  children  and  adolescents  with  sickle-cell  disease  is
requent,  and  that  more  studies  are  required  to  provide  evi-
ence  of  the  association  of  vitamin  D  deﬁciency  with  painful
rises  and  bone  metabolism,  as  well  as  to  assess  the  poten-
ial  therapeutic  beneﬁts  of  vitamin  D  supplementation  in
his  population.
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